Liptak Vincent Paul
General Counsel
Liptak Vincent Paul has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.
On the most recent filing, Liptak Vincent Paul is listed as General Counsel at BlossomHill Therapeutics, Inc. Inside the rolling window, Liptak Vincent Paul reported 2 open-market purchases totaling $75K in BLSM and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,500 BLSM shares on Aug 7, 2026, worth $40K.
Companies traded
Other insiders at BLSM
Insider Buying
$75K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Liptak Vincent Paul made?
Liptak Vincent Paul has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2026.
Which companies does Liptak Vincent Paul trade?
Liptak Vincent Paul has filed SEC Form 4 disclosures for 1 company, including BLSM.
When was Liptak Vincent Paul's most recent SEC Form 4 filing?
Liptak Vincent Paul's most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.
What is Liptak Vincent Paul's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Liptak Vincent Paul is listed as General Counsel.
What is Liptak Vincent Paul's total buy and sell value in the current window?
Inside the rolling retention window, Liptak Vincent Paul bought $75K and sold $0 based on SEC Form 4 filings.
What was Liptak Vincent Paul's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,500 BLSM shares on 2026-08-07, worth $40K, per SEC Form 4 filings.